Lunai Bioworks Inc. (RENB)
1.266
-0.035 (-2.69%)
Inactive · Last trade price on Sep 29, 2025
Lunai Bioworks Employees
Lunai Bioworks had 25 employees as of June 30, 2024. The number of employees increased by 13 or 108.33% compared to the previous year.
Employees
25
Change (1Y)
13
Growth (1Y)
108.33%
Revenue / Employee
n/a
Profits / Employee
-$2,369,248
Market Cap
292.36M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 25 | 13 | 108.33% |
| Jun 30, 2023 | 12 | -10 | -45.45% |
| Jun 30, 2022 | 22 | 11 | 100.00% |
| Jun 30, 2021 | 11 | 1 | 10.00% |
| Jun 30, 2020 | 10 | 2 | 25.00% |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
RENB News
- 6 days ago - Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships - Accesswire
- 7 days ago - Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split - Accesswire
- 20 days ago - Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics - Accesswire
- 22 days ago - Top 3 Health Care Stocks You'll Regret Missing In Q3 - Benzinga
- 22 days ago - Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - Accesswire
- 23 days ago - Lunai Bioworks Strengthens European Strategy Through Restructuring - Accesswire
- 27 days ago - Lunai Bioworks Inc. Retains American Defense International - Accesswire
- 5 weeks ago - Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics - Accesswire